Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Proton Therapy With Capecitabine for Rectal Cancer

This study has been withdrawn prior to enrollment.
(No participant enrollment.)
Sponsor:
Information provided by (Responsible Party):
M.D. Anderson Cancer Center
ClinicalTrials.gov Identifier:
NCT00503932
First received: July 17, 2007
Last updated: March 21, 2012
Last verified: March 2012
No Study Results Posted on ClinicalTrials.gov for this Study
Study was withdrawn before participants were enrolled.
  Study Status: This study has been withdrawn prior to enrollment.
  Study Completion Date: April 2008
  Primary Completion Date: April 2008 (Final data collection date for primary outcome measure)